Trachoma cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Ochuko Ajari (talk | contribs) No edit summary |
||
Line 2: | Line 2: | ||
{{Trachoma}} | {{Trachoma}} | ||
Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
{{CMG}} | {{CMG}} | ||
Line 10: | Line 10: | ||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
[[Category:Needs content]] | |||
[[Category:Blindness]] | [[Category:Blindness]] | ||
[[Category:Ophthalmology]] | [[Category:Ophthalmology]] | ||
Line 20: | Line 18: | ||
[[Category:Tropical disease]] | [[Category:Tropical disease]] | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category: | [[Category:Primary care]] | ||
{{WH}} | |||
{{WS}} |
Revision as of 15:58, 9 April 2013
Trachoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Trachoma cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Trachoma cost-effectiveness of therapy |
Risk calculators and risk factors for Trachoma cost-effectiveness of therapy |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Globally, 84 million people suffer from active infection and nearly 8 million people are visually impaired as a result of this disease. Globally this disease results in an estimated US $2.9 billion in lost productivity every year.